Filing
Spy
Filing
Spy
Home
About
GILD
Gilead Sciences, Inc.
Biopharmaceutical company
CUSIP: 375558103
Healthcare
US
6 holders
Ownership
Activity
Fundamentals
2014 Q4
45 of 52 quarters
Total Value
$288.19M
Total Shares
3.06M
Net Share Change
-3.62M
Activity
4 buying
2 selling
Investor
Value
Shares
Weight
Change
Egerton Capital
$109.04M
1.16M
1.5%
TRIM
-4.54M
(-79.7%)
Egerton Capital
$109.04M
1.16M shares
TRIM
-4.54M
(-79.7%)
Miller Value Partners
$64.92M
688.7K
2.4%
TRIM
-1.6K
(-0.2%)
Miller Value Partners
$64.92M
688.7K shares
TRIM
-1.6K
(-0.2%)
Leon Cooperman
$57.73M
612.5K
1.0%
NEW
Leon Cooperman
$57.73M
612.5K shares
NEW
Bridgewater Associates LP
$50.65M
537.3K
0.4%
ADD
+295.8K
(+122.5%)
Bridgewater Associates LP
$50.65M
537.3K shares
ADD
+295.8K
(+122.5%)
Matrix Asset Advisors
$5.36M
56.9K
0.6%
ADD
+13.8K
(+32.0%)
Matrix Asset Advisors
$5.36M
56.9K shares
ADD
+13.8K
(+32.0%)
Jensen Investment Management
$496.0K
5.3K
0.0%
NEW
Jensen Investment Management
$496.0K
5.3K shares
NEW
GILD — Gilead Sciences, Inc. - FilingSpy